Evaluation of Communication Functions in Children With Cerebral Palsy

Status Completed

Clinical Trial Summary

In this study, investigators aimed to evaluate the communication functions of children between 2-18 with cerebral palsy. Investigators planned to investigate the relationship between communication skills and clinical characteristics and socio-demographic status of the family.

Clinical Trial Description

Cerebral palsy (CP) is a non-progressive, movement-limiting loss of permanent motor function, posture and movement disturbance in the developing brain due to lesion or injury that occurs during the intrauterine period or in the first months of life. Secondary medical problems such as epilepsy, mental retardation, behavior disorder, swallowing problems and musculoskeletal disorders may be seen in these patients. Neuroanatomical problems in the muscles associated with the mouth and speech, and the presence of central pathologies, are important problems in patients with cerebral palsy. Monitoring the communication level of these patients is very important for determining treatment protocols and monitoring their effectiveness. Difficulties in communication significantly affect the rate and level of recovery in patients with cerebral palsy. There are many different scales to analyze communication level and problems in children with cerebral palsy. The most commonly used ones are the Communication Function Classification System (CFCS) and the Functional Communication Classification System (FCCS). By examining the communication level in 5 categories in both scales, it helps to monitor the communicative development of the child and also provides a common language among clinicians. They are defined by the World Health Organization (WHO) and focus on the levels of activity and participation defined in the international classification of function, disability and health.

The aim of this study was to evaluate the communication level in children over 2 years of age with cerebral palsy. In addition, the relationship between communication skills and general functional levels and demographic characteristics will be investigated. In this way, both the general communication level of this patient group and the possible factors affecting this skill will be analyzed. Thus, these relationships and measurements can be utilized in determining treatment and rehabilitation protocols. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04149561
Study type	Observational
Source	Bezmialem Vakif University
Contact
Status	Completed
Phase
Start date	November 1, 2019
Completion date	March 14, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05317234` - Genetic Predisposition in Cerebral Palsy	N/A
Recruiting	`NCT05576948` - Natural History of Cerebral Palsy Prospective Study
Completed	`NCT04119063` - Evaluating Wearable Robotic Assistance on Gait	Early Phase 1
Completed	`NCT03264339` - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy	N/A
Completed	`NCT05551364` - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy	N/A
Completed	`NCT03902886` - Independent Walking Onset of Children With Cerebral Palsy
Recruiting	`NCT05571033` - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy	N/A
Not yet recruiting	`NCT04081675` - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed	`NCT02167022` - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy	N/A
Completed	`NCT04012125` - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy	N/A
Enrolling by invitation	`NCT05619211` - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities	Phase 1
Completed	`NCT04489498` - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed	`NCT03677193` - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy	N/A
Recruiting	`NCT06450158` - Robot-assisted Training in Children With CP	N/A
Completed	`NCT04093180` - Intensive Neurorehabilitation for Cerebral Palsy	N/A
Completed	`NCT02909127` - The Pediatric Eating Assessment Tool
Not yet recruiting	`NCT06377982` - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy	Phase 1
Not yet recruiting	`NCT06007885` - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.	N/A
Not yet recruiting	`NCT03183427` - Corpus Callosum Size in Patients With Pineal Cyst	N/A
Active, not recruiting	`NCT03078621` - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.